Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000029640Phase 4Recruiting
Phase 4, randomised trial of magnesium sulfate and ropivacaine (2 arms), sponsored by Southern Medical University. Primary endpoint: Duration of block. Started Feb 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000029640.